Amundi’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$505K Hold
304,151
– – ﹤0.01% 1658
2026
Q2
$620K Buy
304,151
+12,443
+4% +$22.8K ﹤0.01% 1573
2026
Q1
$522K Buy
291,708
+19,466
+7% +$41.3K ﹤0.01% 1534
2025
Q4
$610K Buy
+272,242
New +$716K ﹤0.01% 1407
2025
Q2
– Sell
-155,953
Closed -$111K – 2056
2025
Q1
$111K Hold
155,953
– – ﹤0.01% 1735
2024
Q4
$259K Hold
155,953
– – ﹤0.01% 1688
2024
Q3
$270K Buy
155,953
+155,812
+110,505% +$354K ﹤0.01% 1586
2024
Q2
$330 Sell
141
-78,043
-100% -$209K ﹤0.01% 1915
2024
Q1
$188K Buy
78,184
+6,341
+9% +$9.32K ﹤0.01% 1645
2023
Q4
$114K Buy
71,843
+16,341
+29% +$35K ﹤0.01% 1748
2023
Q3
$154K Buy
55,502
+13,125
+31% +$126K ﹤0.01% 1663
2023
Q2
$486K Buy
42,377
+4,508
+12% +$48K ﹤0.01% 1398
2023
Q1
$346K Buy
37,869
+14,047
+59% +$150K ﹤0.01% 1432
2022
Q4
$182K Buy
+23,822
New +$228K ﹤0.01% 1529

Other funds holding PROK

Amundi's PROK Position: Q3 2026 in Review

Amundi held its ProKidney (PROK) position steady in Q3 2026 at 304,151 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #1658.

Amundi first reported a position in PROK in Q4 2022 and has held it in 14 quarters since. The position peaked at $620K in Q2 2026. 32 funds tracked by Wall St. Rank hold PROK as of Q3 2026.

  • Amundi held 304,151 shares of ProKidney worth $505K as of Q3 2026.
  • Amundi left its ProKidney share count unchanged in Q3 2026.
  • ProKidney made up ﹤0.01% of Amundi's portfolio in Q3 2026, its #1658 holding.
  • Amundi first reported a position in ProKidney in Q4 2022 and has held it in 14 quarters since.
  • Amundi's ProKidney position peaked at $620K in Q2 2026.
  • 32 funds tracked by Wall St. Rank held ProKidney as of Q3 2026.

Based on Amundi's 13F filing for Q3 2026, filed 6 Nov 2026.